基础医学与临床 ›› 2010, Vol. 30 ›› Issue (12): 1346-1348.

• 短篇综述 • 上一篇    下一篇

miRNAs与肝细胞癌的研究进展

李艳春1,文继舫2   

  1. 1. 湖南省人民医院2. 中南大学湘雅医院
  • 收稿日期:2010-01-07 修回日期:2010-02-24 出版日期:2010-12-05 发布日期:2010-12-05
  • 通讯作者: 李艳春

Research progress of relationship between miRNAs and hepatocellular carcinoma

LI Yan-chun 1,WEN Ji-fang 2   

  1. 1. Hunan Province People’s Hospital2. Xiang-Ya Hospital, Central South University
  • Received:2010-01-07 Revised:2010-02-24 Online:2010-12-05 Published:2010-12-05
  • Contact: LI Yan-chun

摘要: 最近发现一类小分子物质——microRNAs在肝细胞癌中异常表达,其中部分已被证实与肝细胞癌的发生发展密切有关。有些microRNAs与肝细胞癌的分型有关,提示,microRNAs在肝细胞癌的诊断和预后判断中有着潜在的作用;有些microRNAs被证实为肝细胞癌发生的独立危险因素,为临床早期筛查和风险评估提供了分子标记,也为个体化治疗提供了分子依据。

关键词: miRNAs, 肝细胞癌, 瘤基因, 抑瘤基因

Abstract: Recently, a new group of molecules, microRNAs, has been discovered to be aberrantly expressed in HCC and some of them are functionally involved in HCC carcinogenesis and progression. Certain microRNAs are associated with HCC subtypes, implying that microRNAs have a potential role in the diagnosis and prognosis of HCC; some of these HCC-associated microRNAs have been validated in independent cohorts, providing a molecular marker for early screening for clinical and risk assessment, but also providing a molecular basis for individual treatment of HCC.